Vivos Inc. (OTCQB: RDGL) proudly announces the initiation of its first human clinical trial for RadioGel® Precision Radionuclide Therapy in India. This ...
Global medical lasers market will reach $16,239.7 million by 2032, growing by 13.2% annually over 2022-2032, driven by the increasing number of cosmetic procedures, the rising pre ...